Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?

Autor: Garraud O; SAINBIOSE INSERM U1049, Université de Saint-Etienne, Saint-Etienne, France. Electronic address: olivier.garraud@univ-st-etienne.fr., Watier H; CPER INSERM U1100 and Université de Tours, and CHRU de Tours, Tours, France.
Jazyk: angličtina
Zdroj: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Jun; Vol. 62 (3), pp. 103726. Date of Electronic Publication: 2023 May 08.
DOI: 10.1016/j.transci.2023.103726
Databáze: MEDLINE